ReSurfX is a new breed of Big Data based outcomes intelligence company focused on improving innovation, outcomes and ROI to enterprises through superior data utilization and data generation (measurement technology redesigns) solutions. We leverage our novel data-source agnostic machine learning approach 'Adaptive Hypersurface Technology' (AHT) to deliver value to the market as artificial intelligence (AI) driven solutions (e.g., our Advance Outcomes Alert System - AOAS) enabling experts to add superior value to their enterprise effectively. Our focus is on end-to-end solutions for Pharma and Biotech enterprises and healthcare sector (spanning discovery - clinical trial - high cost product sale and medical care with quantitative evidence). We have many issued patents and other proprietary IP supporting our solutions.
This page gives a quick outline about us. You can find detailed information from navigation bar of this website and may links therein.
- Rapid fire introduction video.
- Enterprise grade and integrative SaaS Product (ReSurfX::vysen 2.0) showcasing market leading predictive power and accuracy using gene expression technologies with two extremes of input data properties, predicting triggers and outcomes from system response and more.
Contact us now for the INNOVATE FASTER DURING COVID-19 PANDEMIC SPECIAL PRICING THROUGH THE END OF YEAR 2020!
Below is a quick outline of our propositions and market value (a version used in CIO Review magazine when we were recognized as 20 Most Promising Analytics Vendors)
*please refresh page if the following pdf does not auto-load